Seamless Therapeutics
PrivateLast Round
Seed
Apr 23, 2024
Total Funding Raised
$37.5M
Company Overview
Seamless Therapeutics operates in Healthcare & Life Sciences and is based in Dresden. Its latest recorded funding round was a Seed round in April 2024.
Seamless Therapeutics is a biotechnology company developing a gene-editing platform using programmable recombinases to create therapies for severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seamless Therapeutics Comparables
Compare Seamless Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PROVIREX Genome Editing Therapies GmbH | 86% | |
| Stylus Medicine | 82% | |
| Brink Therapeutics | 82% |
For institutional investors. Book with your work email.
Seamless Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 23, 2024 | ||||
| Seed | Mar 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Seamless Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Seed |
| UCB Ventures | Seed |
| Gründungsoffensive Biotechnologie (GO-Bio) of the Federal Ministry of Education and Research (BMBF) | Seed |
| Wellington Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 6, 2026
Global agreement to develop treatments for hearing loss indications.
- Jan 1, 2026
Partnered to develop treatments for hearing loss in January 2026.
For institutional investors. Book with your work email.
Seamless Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Seamless Therapeutics's valuation, stock price, and market status.
Is Seamless Therapeutics a public or private company?
Seamless Therapeutics is a private company.
What is the current stock price of Seamless Therapeutics?
Seamless Therapeutics is a private company, so its shares have no public market price. Caplight tracks Seamless Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Seamless Therapeutics worth (valuation)?
Valuation information for Seamless Therapeutics is not publicly available.
Can I buy Seamless Therapeutics stock?
Seamless Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Seamless Therapeutics's last funding round?
Seamless Therapeutics's most recent funding round was Seed on April 23, 2024.
Who are the main investors in Seamless Therapeutics?
Key investors in Seamless Therapeutics include Forbion, Wellington Partners.
Will Seamless Therapeutics IPO soon?
No public IPO plans have been announced for Seamless Therapeutics.
How can I track Seamless Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Seamless Therapeutics's shares on secondary markets.